Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Ashley, DM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 26 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Riffkin, CD; Gray, AZ; Hawkins, CJ; Chow, CW; Ashley, DM
      Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and areresistant to apoptosis induction

      NEURO-ONCOLOGY
    2. Hassall, TEG; Mitchell, AE; Ashley, DM
      Carboplatin chemotherapy for progressive intramedullary spinal cord low-grade gliomas in children: Three case studies and a review of the literature

      NEURO-ONCOLOGY
    3. Hawkins, CJ; Silke, J; Verhagen, AM; Foster, R; Ekert, PG; Ashley, DM
      Analysis of candidate antagonists of IAP-mediated caspase inhibition usingyeast reconstituted with the mammalian Apaf-1-activated apoptosis mechanism

      APOPTOSIS
    4. Knight, MJ; Riffkin, CD; Muscat, AM; Ashley, DM; Hawkins, CJ
      Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells

      ONCOGENE
    5. Ashley, DM
      Counterpoint - 'Chemotherapy is useful in treatment of gliomas' - Discussant

      JOURNAL OF CLINICAL NEUROSCIENCE
    6. Friedman, HS; Pluda, J; Quinn, JA; Ewesuedo, RB; Long, L; Friedman, AH; Cokgor, I; Colvin, OM; Haglund, MM; Ashley, DM; Rich, JN; Sampson, J; Pegg, AE; Moschel, RC; McLendon, RE; Provenzale, JM; Stewart, ES; Tourt-Uhlig, S; Garcia-Turner, AM; Herndon, JE; Bigner, DD; Dolan, ME
      Phase I trial of carmustine plus O-6-benzylguanine for patients with recurrent or progressive malignant glioma

      JOURNAL OF CLINICAL ONCOLOGY
    7. Bottom, KS; Ashley, DM; Friedman, HS; Longee, DC
      Evaluation of pre-radiotherapy cyclophosphamide in patients with newly diagnosed glioblastoma multiforme

      JOURNAL OF NEURO-ONCOLOGY
    8. Sampson, JH; Crotty, LE; Lee, S; Archer, GE; Ashley, DM; Wikstrandt, CJ; Hale, LP; Small, C; Dranoff, G; Friedman, AH; Friedman, HS; Bigner, DD
      Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    9. Scarcella, DL; Chow, CW; Gonzales, MF; Economou, C; Brasseur, F; Ashley, DM
      Expression of MAGE and GAGE in high-grade brain tumors: A potential targetfor specific immunotherapy and diagnostic markers

      CLINICAL CANCER RESEARCH
    10. FRIEDMAN HS; KOKKINAKIS DM; PLUDA J; FRIEDMAN AH; COKGOR I; HAGLUND MM; ASHLEY DM; RICH J; DOLAN ME; PEGG AE; MOSCHEL RC; MCLENDON RE; KERBY T; HERNDON JE; BIGNER DD; SCHOLD SC
      PHASE-I TRIAL OF O-6-BENZYLGUANINE FOR PATIENTS UNDERGOING SURGERY FOR MALIGNANT GLIOMA

      Journal of clinical oncology
    11. Friedman, HS; McLendon, RE; Kerby, T; Dugan, M; Bigner, SH; Henry, AJ; Ashley, DM; Krischer, J; Lovell, S; Rasheed, K; Marchev, F; Seman, AJ; Cokgor, I; Rich, J; Stewart, E; Colvin, OM; Provenzale, JM; Bigner, DD; Haglund, MM; Friedman, AH; Modrich, PL
      DNA mismatch repair and O-6-alkylguanine-DNA alkyltransferase analysis andresponse to temodal in newly diagnosed malignant glioma

      JOURNAL OF CLINICAL ONCOLOGY
    12. ASHLEY DM; SAMPSON JH; ARCHER GE; HALE LP; BIGNER DD
      LOCAL PRODUCTION OF TGF-BETA-1 INHIBITS CEREBRAL EDEMA, ENHANCES TNF-ALPHA INDUCED APOPTOSIS AND IMPROVES SURVIVAL IN A MURINE GLIOMA MODEL

      Journal of neuroimmunology
    13. ASHLEY DM; KONG FM; BIGNER DD; HALE LP
      ENDOGENOUS EXPRESSION OF TRANSFORMING-GROWTH-FACTOR BETA-1 INHIBITS GROWTH AND TUMORIGENICITY AND ENHANCES FAS-MEDIATED APOPTOSIS IN A MURINE HIGH-GRADE GLIOMA MODEL

      Cancer research
    14. ASHLEY DM; BIGNER DD
      RECENT ADVANCES IN THE BIOLOGY OF CENTRAL-NERVOUS-SYSTEM TUMORS

      Current opinion in neurology
    15. ASHLEY DM; COLEMAN RE; FUCHS H; DEAR G; GINSBERG B; ZALDUONDO FM; FRIEDMAN HS; LONGEE D
      CHRONIC CSF LEAK INTO THE PERITONEAL-CAVITY SHOWN BY RADIONUCLIDE CISTERNOGRAPHY - SUCCESSFUL TREATMENT WITH AN EPIDURAL BLOOD PATCH

      Clinical nuclear medicine
    16. ASHLEY DM; BATRA SK; BIGNER DD
      MONOCLONAL-ANTIBODIES TO GROWTH-FACTORS AND GROWTH-FACTOR RECEPTORS -THEIR DIAGNOSTIC AND THERAPEUTIC POTENTIAL IN BRAIN-TUMORS

      Journal of neuro-oncology
    17. ASHLEY DM; SAMPSON JH; ARCHER GE; BATRA SK; BIGNER DD; HALE LP
      A GENETICALLY-MODIFIED ALLOGENEIC CELLULAR VACCINE GENERATES MHC CLASS I-RESTRICTED CYTOTOXIC RESPONSES AGAINST TUMOR-ASSOCIATED ANTIGENS AND PROTECTS AGAINST CNS TUMORS IN-VIVO

      Journal of neuroimmunology
    18. SAMPSON JH; ASHLEY DM; ARCHER GE; FUCHS HE; DRANOFF G; HALE LP; BIGNER DD
      CHARACTERIZATION OF SPONTANEOUS MURINE ASTROCYTOMA AND ABROGATION OF ITS TUMORIGENICITY BY CYTOKINE SECRETION

      Neurosurgery
    19. ASHLEY DM; FAIOLA B; NAIR S; HALE LP; BIGNER DD; GILBOA E
      BONE MARROW-GENERATED DENDRITIC CELLS PULSED WITH TUMOR EXTRACTS OR TUMOR RNA INDUCE ANTITUMOR IMMUNITY AGAINST CENTRAL-NERVOUS-SYSTEM TUMORS

      The Journal of experimental medicine
    20. ASHLEY DM; LONGEE D; TIEN R; FUCHS H; GRAHAM ML; KURTZBERG O; CASEY J; OLSON J; MEIER L; FERRELL L; KERBY T; DUNCANBROWN M; STEWART E; COLVIN OM; PIPAS JM; MCCOWAGE G; MCLENDON R; BIGNER DD; FRIEDMAN HS
      TREATMENT OF PATIENTS WITH PINEALOBLASTOMA WITH HIGH-DOSE CYCLOPHOSPHAMIDE

      Medical and pediatric oncology
    21. SAMPSON JH; ARCHER GE; ASHLEY DM; FUCHS HE; HALE LP; DRANOFF G; BIGNER DD
      SUBCUTANEOUS VACCINATION WITH IRRADIATED, CYTOKINE-PRODUCING TUMOR-CELLS STIMULATES CD8(-MEDIATED-IMMUNITY AGAINST TUMORS LOCATED IN THE IMMUNOLOGICALLY PRIVILEGED CENTRAL-NERVOUS-SYSTEM() CELL)

      Proceedings of the National Academy of Sciences of the United Statesof America
    22. ASHLEY DM; BOL SJ; TUCKER DP; WAUGH CM; KANNOURAKIS G
      FLOW CYTOMETRIC ANALYSIS OF INTERCELLULAR-ADHESION BETWEEN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIC-CELLS AND BONE-MARROW STROMAL CELLS

      Leukemia
    23. ASHLEY DM; BOL SJ; KANNOURAKIS G
      VIABLE BONE-MARROW STROMAL CELLS ARE REQUIRED FOR THE IN-VITRO SURVIVAL OF B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIC-CELLS

      Leukemia research
    24. ASHLEY DM; BOL SJ; KANNOURAKIS G
      HUMAN BONE-MARROW STROMAL CELL CONTACT AND SOLUBLE FACTORS HAVE DIFFERENT EFFECTS ON THE SURVIVAL AND PROLIFERATION OF PEDIATRIC B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIC BLASTS

      Leukemia research
    25. ASHLEY DM; BOL SJ; KANNOURAKIS G
      MEASUREMENT OF THE GROWTH-PARAMETERS OF PRECURSOR B-ACUTE LYMPHOBLASTIC LEUKEMIC-CELLS IN COCULTURE WITH BONE-MARROW STROMAL CELLS - DETECTION OF 2 CD10 POSITIVE POPULATIONS WITH DIFFERENT PROLIFERATIVE CAPACITIES AND SURVIVAL

      Leukemia research
    26. ASHLEY DM; BOL SJ; WAUGH C; KANNOURAKIS G
      A NOVEL-APPROACH TO THE MEASUREMENT OF DIFFERENT IN-VITRO LEUKEMIC-CELL GROWTH-PARAMETERS - THE USE OF PKH GL FLUORESCENT-PROBES

      Leukemia research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 22:16:56